Gilead Sciences
GILD
#95
Rank
S$228.77 B
Marketcap
S$184.28
Share price
-0.56%
Change (1 day)
23.97%
Change (1 year)

EPS for Gilead Sciences (GILD)

EPS in 2025 (TTM): S$8.54

According to Gilead Sciences's latest financial reports the company's current EPS (TTM) is S$8.32. In 2024 the company made an earnings per share (EPS) of S$0.48 a decrease over its 2023 EPS that were of S$5.81.

EPS history for Gilead Sciences from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S$8.541660.26%
2024S$0.48-91.65%
2023S$5.8123.98%
2022S$4.68-25.86%
2021S$6.324850%
2020S$0.13-97.64%
2019S$5.410.9%
2018S$5.3618.71%
2017S$4.52-64.88%
2016S$12.86-18.45%
2015S$15.7755.28%
2014S$10.16296.02%
2013S$2.5717.89%
2012S$2.18

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$14.21 70.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$1.74-79.14%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
S$3.05-63.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$29.38 253.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$18.29 119.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$14.03 68.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
S$5.70-31.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
S$18.29 119.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$9.32 12.07%๐Ÿ‡บ๐Ÿ‡ธ USA